Dimension Capital Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$204K Buy
222
+7
+3% +$7.1K 0.03% 119
2025
Q4
$231K Buy
+215
New +$206K 0.03% 108

Other funds holding LLY

Dimension Capital Management's LLY Position: Q1 2026 in Review

Dimension Capital Management increased its Eli Lilly (LLY) stake by 3.3% in Q1 2026, buying an estimated $7.1K and bringing the position to 222 shares worth $204K. The position accounts for 0.03% of the portfolio, ranked #119.

Dimension Capital Management first reported a position in LLY in Q4 2025 and has held it in 2 quarters since. The position peaked at $231K in Q4 2025. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Dimension Capital Management held 222 shares of Eli Lilly worth $204K as of Q1 2026.
  • Dimension Capital Management bought 7 Eli Lilly shares in Q1 2026, an estimated $7.1K.
  • Eli Lilly made up 0.03% of Dimension Capital Management's portfolio in Q1 2026, its #119 holding.
  • Dimension Capital Management first reported a position in Eli Lilly in Q4 2025 and has held it in 2 quarters since.
  • Dimension Capital Management's Eli Lilly position peaked at $231K in Q4 2025.
  • 4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Dimension Capital Management's 13F filing for Q1 2026, filed 15 May 2026.